drugset / Trial / NCT00115037

Managing Alcoholism in People Who Do Not Respond to Naltrexone

NCT00115037

Phase 4 Completed 302 enrolled University of Pennsylvania
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a study involving treatment for alcohol dependence (alcoholism). The study will combine motivational enhancement therapy and cognitive behavioral therapy (combined behavioral intervention, or CBI) and tests the benefits of continued/discontinued treatment with naltrexone in a randomized placebo-controlled trial. CBI may have advantages in motivating patients to greater medication adherence and may address psychosocial factors that may limit the effects of naltrexone.

Timeline

Start
2003-09
Primary completion
2008-04
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Naltrexone Small molecule 100 mg

Indications